About this product

Name: Bromazolam Cas: 71368-80-4

Other names: Bromazola; bromazolon; bromazolam; 71368-80-four

Bromazolam is a designer benzodiazepine that is not approved for medical use. This article will delve into bromazolam’s specifics, safety profile, and other alternatives. Bromazolam is a benzodiazepine derivative that was first synthesized in 1976 but was never marketed. It is not available as a prescription medication as it has not been approved for medical use yet.

Bromazolam is primarily metabolized in the liver by the cytochrome P450 (CYP450) enzyme complex, including CYP3A4. Bromazolam has an onset of action of 15 to 45 minutes following oral intake. Its effect lasts from 5 to 8 hours, while after-effects may last from 1 to 12 hours.